SEARCH

SEARCH BY CITATION

References

  • 1
    Kittleson MD, Kienle RD. Small Animal Cardiovascular Medicine. St. Louis , MO : Mosby; 1998: 155157.
  • 2
    Opie LH. Drugs for the Heart. Philadelphia , PA : WB Saunders; 1997: 8487.
  • 3
    Bristow MR, Port JD, Kelly RA. Treatment of heart failure: Pharmacological methods. In: Heart Disease: A Textbook of Cardiovascular Medicine. Philadelphia , PA : WB Saunders; 2001: 568569.
  • 4
    Brater DC. Diuretic therapy. N Engl J Med 1998;339:387395.
  • 5
    Van Meyel JJM, Smits P., Russel FGM, et al. Diuretic efficacy of furosemide during continuous administration versus bolus injection in healthy volunteers. Clin Pharmacol Ther 1992;51:440444.
  • 6
    Singh NC, Kissoon N., Mofada SA, et al. Comparison of continuous versus intermittent furosemide administration in postoperative pediatric cardiac patients. Crit Care Med 1992;20:1721.
  • 7
    van der Vorst MMJ, Ruys-Dudok van Heel I., Kist-van Holthe JE, et al. Continuous intravenous furosemide in haemodynamically unstable children after cardiac surgery. Int Care Med 2001; 27: 711715.
  • 8
    Luciani GB, Nichani S., Chang AC, et al. Continuous versus intermittent furosemide infusion in critically ill infants after open heart operations. Ann Thorac Surg 1997;64:11331139.
  • 9
    Dormans TPJ, Van Meyel JJM, Gerlag PGG, et al. Diuretic efficacy of high dose furosemide in severe heart failure: Bolus injection versus continuous infusion. J Am Coll Cardiol 1996;28:376382.
  • 10
    Yelton SC, Gaylor MA, Murray KM. The role of continuous infusion of loop diuretics. Ann Pharmacother 1995;29:10101014.
  • 11
    Johansson AM, Gardner SY, Levine JF, et al. Furosemide continuous rate infusion in the horse. J Vet Intern Med 2002; 16: 355A (abstract).
  • 12
    Lee MG, Li T., Chiou WL. Effect of intravenous infusion time on the pharmacokinetics and pharmacodynamics of the same total dose of furosemide. Biopharm Drug Dispos 1986;7:537547.
  • 13
    Adin DB, Hill RC, Scott KC. Short term compatibility of fu-rosemide with crystalloid solutions. J Vet Int Med 2003; 17: 724726.
  • 14
    Dunnett CW. A multiple comparison procedure for comparing several treatments with a control. J Am Stat Assoc 1955; 50: 10961121.
  • 15
    Hill R., Lewis D., Scott K., et al. Effect of increased dietary protein and decreased dietary carbohydrates on performance and body composition in racing Greyhounds. Am J Vet Res 2001;62:440447.
  • 16
    Van Meyel JJM, Smits P., Dormans T., et al. Continuous infusion of furosemide in the treatment of patients with congestive heart failure and diuretic resistance. J Int Med 1994;235:329334.
  • 17
    Sjostrom PA, Kron BG, Odline BC. Changes in renal clearance of furosemide due to changes in renal blood flow and plasma albumin concentration. Eur J Clin Pharmacol 1993;45:135139.
  • 18
    Miyazaki H., Hirai J., Taneike T. The pharmacokinetics and phar-macodynamics of furosemide in anesthetized dogs with normal and experimentally decreased renal function. Nippon Juigaku Zasshi 1990; 52:265273.
  • 19
    El-Sayed MG, Atef M., El-Gendi AY, Youssef SA. Disposition kinetics of furosemide in dogs. Arch Int Pharmacodyn Ther 1981; 253: 410.
  • 20
    Hirai J., Miyazaki H., Taneike T. The pharmacokinetics and phar-macodynamics of furosemide in the anesthetized dog. J Vet Pharmacol Ther 1992;15:231239.
  • 21
    Bayliss J., Norell M., Canepa-Anson R., et al. Untreated heart failure: Clinical and neuroendocrine effects of introducing diuretics. Br Heart J 1987;57:1722.
  • 22
    Aaser E., Gullestad L., Tollofsrud S., et al. Effect of bolus injection versus continuous infusion of furosemide on diuresis and neuro-hormonal activation in patients with severe congestive heart failure. Scand J Clin Lab Invest 1997;57:361368.